Akụkọ

Nsonaazụ dị mkpa nke ọgwụgwọ CAR-T nke CD7 maka T-ALL na T-LBL
Nnyocha e mere n'oge na-adịbeghị anya na-egosi nsonaazụ dị mma nke ọgwụgwọ mkpụrụ ndụ T nke CD7-targeted chimeric antigen receptor (CAR) na-agwọ ndị ọrịa nwere ọrịa leukemia T-cell acute lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL) nke na-alaghachi azụ ma ọ bụ na-adịghị ike.

Mkpuchi nke Nzukọ na Ngosipụta Kwa Afọ nke 2024 ASH
A ga-enwe Nzukọ Kwa Afọ nke 66 nke American Society of Hematology (ASH) site na Disemba 7 ruo 10, 2024, na San Diego Convention Center, na-egosi nchọpụta na ọganihu dị ukwuu na hematology.

Ịkpọsa Nzukọ Ọgwụ Lu Daopei nke Afọ 2024 n'ọnwa Ọgọst
A ga-eme ogbako Lu Daopei Hematology nke afọ nke iri na abụọ n'ụbọchị iri abụọ na atọ ruo iri abụọ na anọ nke ọnwa Ọgọst, afọ 2024, na Beijing International Convention Center. Soro anyị maka mkparịta ụka bara uru na ọganihu kachasị ọhụrụ na hematology.

Olileanya Ọhụrụ n'Ọgwụgwọ Ọrịa Kansa: Ọgwụgwọ TILs Na-apụta dị ka Ebe Na-esote
N'agbanyeghị ihe ịma aka ndị na-aga n'ihu n'ịzụlite na ire ahịa n'ụlọ ọrụ mmepụta ihe, a na-edozi oke ọgwụgwọ CAR-T site na ụzọ ọhụrụ dị mma: ọgwụgwọ Lymphocytes nke na-abanye n'ime ahụ (TIL). Ihe ọhụrụ a na-egosi oge ọhụrụ n'ọgụ megide etuto ahụ siri ike.
Ọgwụgwọ Cellular Ọ̀ Bụ Ọdịnihu nke Ọrịa Mgbochi Onwe?
Ọgwụgwọ ọhụrụ maka ọrịa kansa nwekwara ike inye aka gwọọ ma tọgharịa sistemu ahụ ji alụso ọrịa ọgụ iji nye mgbaghara ogologo oge ma ọ bụ ikekwe gwọọ ụfọdụ ọrịa autoimmune.

Mmepe ASH nke 2023 | Dr. Peihua Lu na-egosi CAR-T maka Nnyocha AML Relapsed/Refractory

ASH 2023|"Olu Lu Daopei" na-abụ abụ n'elu ikpo okwu mba ụwa











